EXACT Therapeutics AS (OSL:EXTX)
1.600
0.00 (0.00%)
At close: Apr 1, 2026
EXACT Therapeutics AS Market Cap
EXACT Therapeutics AS has a market cap or net worth of 101.22 million as of April 2, 2026. Its market cap has decreased by -53.49% in one year.
Market Cap
101.22M
Enterprise Value
43.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since July 14, 2020, EXACT Therapeutics AS's market cap has decreased from 953.69M to 101.22M, a decrease of -89.39%. That is a compound annual growth rate of -32.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 101.22M | 15.94% |
| Dec 30, 2025 | 87.30M | -63.30% |
| Dec 30, 2024 | 237.87M | -38.21% |
| Dec 29, 2023 | 384.97M | 6.95% |
| Dec 30, 2022 | 359.97M | -31.02% |
| Dec 30, 2021 | 521.86M | -40.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.32B |
| Thor Medical ASA | 1.77B |
| Nykode Therapeutics AS | 1.12B |
| ArcticZymes Technologies ASA | 1.00B |
| Lytix Biopharma AS | 799.76M |
| Zelluna ASA | 493.35M |
| SoftOx Solutions AS | 277.64M |
| Oncoinvent ASA | 209.23M |